TY - JOUR AU - Kashiwagi, Kenji AU - Tsukahara, Shigeo PY - 2014 DA - 2014年01月15日TI -患者访问互联网健康记录对青光眼用药的影响:随机对照试验JO - J Med Internet Res SP - e15 VL - 16 IS - 1kw -互联网KW -青光眼KW -眼压KW -个人健康记录KW -用药AB -背景:青光眼是致盲的主要原因之一。降低眼压是预防青光眼视神经病变进展的唯一有效方法。大多数青光眼患者一生中都需要使用抗青光眼眼药水。因此，良好的青光眼治疗依从性和持久性是更好的青光眼护理的重要因素。目的:本研究旨在探讨基于互联网的青光眼护理支持系统对青光眼药物使用的影响。方法:将患者随机分为两组。非互联网接入(NIA)组由在4年期间仅在眼科医生检查时才使用基于互联网的青光眼护理支持系统的患者组成。互联网接入(IA)组由在入组后的前2年与NIA组具有相同的基于互联网的青光眼护理支持系统接入的患者组成，但在剩余的2年也可免费访问青光眼护理支持系统。调查青光眼药物使用的变化。结果:IA组共81例患者，NIA组共90例患者符合研究方案。 The number of antiglaucoma ophthalmic solutions used during the study period significantly increased in the NIA group (P<.03) but not in the IA group. The percentages of patients with unchanged, increased, and decreased antiglaucoma ophthalmic solution use during the study period were 61.1% (55/90), 17.8% (16/90), and 3.3% (3/90), respectively, in the NIA group, and 56.8% (46/81), 8.6% (7/81), and 13.6% (11/81), respectively, in the IA group (P<.001). Internet access significantly shifted from an increasing intraocular pressure trend to a decreasing trend in the IA group (P=.002) among the patients who did not have any medication changes. Conclusions: Allowing patients to browse their medical data may reduce the use and improve the effectiveness of glaucoma medication. Trial Registration: UMIN-CTR Clinical Trial Number: UMIN000006982; https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr.cgi?function=brows&action=brows&type=summary&recptno=R000008238&language=E (Archived by WebCite at http://www.webcitation.org/6MRPQeEAv). SN - 14388871 UR - //www.mybigtv.com/2014/1/e15/ UR - https://doi.org/10.2196/jmir.2795 UR - http://www.ncbi.nlm.nih.gov/pubmed/24429379 DO - 10.2196/jmir.2795 ID - info:doi/10.2196/jmir.2795 ER -